Global Clinical Diagnostics Market 2021-2031 by Test (Lipid Panel, Infectious Disease Testing, Liver Panel, CBC), Product (Instruments, Assay Kits & Reagents, Software & Services), Indication (Cardiovascular, Cancer, Infectious Disease), Patient Gender (Male, Female), Age Group (44 and below, 45-64, 65 and over), End User, and Region: Trend Forecast and Growth Opportunity

February 2022 | 170 pages | ID: G11F713C6FCEEN
GMD Research

Abstracts

Global clinical diagnostics market will reach $ 135,531.4 million by 2031, growing by 7.4% annually over 2021-2031, driven by the rising patient awareness and rising demand for high-quality care amid the COVID-19 pandemic, growing healthcare spend, technological advancement, benefits of clinical diagnostics such as quick test results and easy procedure, increasing prevalence of chronic diseases caused due to sedentary lifestyle such as diabetes, cardiovascular diseases, high blood pressure, lipid disorders, kidney diseases and cancer.

Highlighted with 82 tables and 94 figures, this 170-page report “Global Clinical Diagnostics Market 2021-2031 by Test (Lipid Panel, Infectious Disease Testing, Liver Panel, CBC), Product (Instruments, Assay Kits & Reagents, Software & Services), Indication (Cardiovascular, Cancer, Infectious Disease), Patient Gender (Male, Female), Age Group (44 and below, 45-64, 65 and over), End User, and Region: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire global clinical diagnostics market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

In-depth qualitative analyses include identification and investigation of the following aspects:

• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces

The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify global clinical diagnostics market in every aspect of the classification from perspectives of by Test, Product, Indication, Patient Gender, Age Group, End User, and Region.

Based on Test, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

• Lipid Panel
• Infectious Disease Testing
• Liver Panel
• Complete Blood Count (CBC)
• Electrolyte Testing
• Renal Panel
• Other Tests

Based on Product, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

• Instruments
• Assay Kits & Reagents
• Software & Services

By Indication the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

• Cardiovascular
• Cancer
• Infectious Disease
• Stroke
• Chronic Lower Respiratory Diseases
• Diabetes
• Other Indications

By Patient Gender the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

• Male Patients
• Female Patients

By Age Group the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

• Age 44 and below
• Age 45-64
• Age 65 and over

By End User the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

• Hospital & Clinics Laboratory
• Diagnostic Laboratory
• Point-of-Care Testing
• Other End Users

Geographically, the following regions together with the listed national/local markets are fully investigated:

• North America (U.S., Canada, and Mexico)
• Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe; Rest of Europe is further segmented into Netherlands, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)
• APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
• South America (Brazil, Chile, Argentina, Rest of South America)
• MEA (UAE, Saudi Arabia, South Africa, Other Nations)

For each aforementioned region and country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of all regional markets by country and split of key national markets by Test, Product, and Indication, over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

Selected Key Players:

• Abbott Laboratories
• Becton, Dickinson and Company
• BioMerieux SA
• Bio-Rad Laboratories Inc.
• Bio-Reference Laboratories
• Bioscientia Healthcare
• Charles River Laboratories
• Danaher Corporation
• Hoffmann-La Roche AG
• Hologic Inc.
• Qiagen NV
• Siemens Healthcare
• Thermo Fisher Scientific

(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Contents

1 INTRODUCTION

1.1 Industry Definition and Research Scope
  1.1.1 Industry Definition
  1.1.2 Research Scope
1.2 Research Methodology
  1.2.1 Overview of Market Research Methodology
  1.2.2 Market Assumption
  1.2.3 Secondary Data
  1.2.4 Primary Data
  1.2.5 Data Filtration and Model Design
  1.2.6 Market Size/Share Estimation
  1.2.7 Research Limitations
1.3 Executive Summary

2 MARKET OVERVIEW AND DYNAMICS

2.1 Market Size and Forecast
  2.1.1 Impact of COVID-19 on World Economy
  2.1.2 Impact of COVID-19 on the Market
2.2 Major Growth Drivers
2.3 Market Restraints and Challenges
2.4 Emerging Opportunities and Market Trends
2.5 Porter’s Fiver Forces Analysis

3 SEGMENTATION OF GLOBAL MARKET BY TEST

3.1 Market Overview by Test
3.2 Lipid Panel
3.3 Infectious Disease Testing
3.4 Liver Panel
3.5 Complete Blood Count (CBC)
3.6 Electrolyte Testing
3.7 Renal Panel
3.8 Other Tests

4 SEGMENTATION OF GLOBAL MARKET BY PRODUCT

4.1 Market Overview by Product
4.2 Instruments
4.3 Assay Kits & Reagents
4.4 Software & Services

5 SEGMENTATION OF GLOBAL MARKET BY INDICATION

5.1 Market Overview by Indication
5.2 Cardiovascular
5.3 Cancer
5.4 Infectious Disease
5.5 Stroke
5.6 Chronic Lower Respiratory Diseases
5.7 Diabetes
5.8 Other Indications

6 SEGMENTATION OF GLOBAL MARKET BY PATIENT GENDER

6.1 Market Overview by Patient Gender
6.2 Male Patients
6.3 Female Patients

7 SEGMENTATION OF GLOBAL MARKET BY AGE GROUP

7.1 Market Overview by Age Group
7.2 Age 44 and below
7.3 Age 45-64
7.4 Age 65 and over

8 SEGMENTATION OF GLOBAL MARKET BY END USER

8.1 Market Overview by End User
8.2 Hospital & Clinics Laboratory
8.3 Diagnostic Laboratory
8.4 Point-of-Care Testing
8.5 Other End Users

9 SEGMENTATION OF GLOBAL MARKET BY REGION

9.1 Geographic Market Overview 2021-2031
9.2 North America Market 2021-2031 by Country
  9.2.1 Overview of North America Market
  9.2.2 U.S.
  9.2.3 Canada
  9.2.4 Mexico
9.3 European Market 2021-2031 by Country
  9.3.1 Overview of European Market
  9.3.2 Germany
  9.3.3 U.K.
  9.3.4 France
  9.3.5 Spain
  9.3.6 Italy
  9.3.7 Russia
  9.3.8 Rest of European Market
9.4 Asia-Pacific Market 2021-2031 by Country
  9.4.1 Overview of Asia-Pacific Market
  9.4.2 Japan
  9.4.3 China
  9.4.4 Australia
  9.4.5 India
  9.4.6 South Korea
  9.4.7 Rest of APAC Region
9.5 South America Market 2021-2031 by Country
  9.5.1 Argentina
  9.5.2 Brazil
  9.5.3 Chile
  9.5.4 Rest of South America Market
9.6 MEA Market 2021-2031 by Country
  9.6.1 UAE
  9.6.2 Saudi Arabia
  9.6.3 South Africa
  9.6.4 Other National Markets

10 COMPETITIVE LANDSCAPE

10.1 Overview of Key Vendors
10.2 New Product Launch, Partnership, Investment, and M&A
10.3 Company Profiles
Abbott Laboratories
Becton, Dickinson and Company
BioMerieux SA
Bio-Rad Laboratories Inc.
Bio-Reference Laboratories
Bioscientia Healthcare
Charles River Laboratories
Danaher Corporation
Hoffmann-La Roche AG
Hologic Inc.
Qiagen NV
Siemens Healthcare
Thermo Fisher Scientific
RELATED REPORTS

List Of Tables

LIST OF TABLES:

Table 1. Snapshot of Global Clinical Diagnostics Market in Balanced Perspective, 2021-2031
Table 2. World Economic Outlook, 2021-2031
Table 3. World Health Spending by Region, $ bn, 2013-2020
Table 4. Main Product Trends and Market Opportunities in Global Clinical Diagnostics Market
Table 5. Global Clinical Diagnostics Market by Test, 2021-2031, $ mn
Table 6. Global Clinical Diagnostics Market by Product, 2021-2031, $ mn
Table 7. Global Clinical Diagnostics Market by Indication, 2021-2031, $ mn
Table 8. Global Clinical Diagnostics Market by Patient Gender, 2021-2031, $ mn
Table 9. Global Clinical Diagnostics Market by Age Group, 2021-2031, $ mn
Table 10. Global Clinical Diagnostics Market by End User, 2021-2031, $ mn
Table 11. Global Clinical Diagnostics Market by Region, 2021-2031, $ mn
Table 12. Leading National Clinical Diagnostics Market, 2021 and 2031, $ mn
Table 13. North America Clinical Diagnostics Market by Country, 2021-2031, $ mn
Table 14. U.S. Clinical Diagnostics Market by Test, 2021-2031, $ mn
Table 15. U.S. Clinical Diagnostics Market by Product, 2021-2031, $ mn
Table 16. U.S. Clinical Diagnostics Market by Indication, 2021-2031, $ mn
Table 17. Canada Clinical Diagnostics Market by Test, 2021-2031, $ mn
Table 18. Canada Clinical Diagnostics Market by Product, 2021-2031, $ mn
Table 19. Canada Clinical Diagnostics Market by Indication, 2021-2031, $ mn
Table 20. Mexico Clinical Diagnostics Market by Test, 2021-2031, $ mn
Table 21. Mexico Clinical Diagnostics Market by Product, 2021-2031, $ mn
Table 22. Mexico Clinical Diagnostics Market by Indication, 2021-2031, $ mn
Table 23. Europe Clinical Diagnostics Market by Country, 2021-2031, $ mn
Table 24. Germany Clinical Diagnostics Market by Test, 2021-2031, $ mn
Table 25. Germany Clinical Diagnostics Market by Product, 2021-2031, $ mn
Table 26. Germany Clinical Diagnostics Market by Indication, 2021-2031, $ mn
Table 27. U.K. Clinical Diagnostics Market by Test, 2021-2031, $ mn
Table 28. U.K. Clinical Diagnostics Market by Product, 2021-2031, $ mn
Table 29. U.K. Clinical Diagnostics Market by Indication, 2021-2031, $ mn
Table 30. France Clinical Diagnostics Market by Test, 2021-2031, $ mn
Table 31. France Clinical Diagnostics Market by Product, 2021-2031, $ mn
Table 32. France Clinical Diagnostics Market by Indication, 2021-2031, $ mn
Table 33. Spain Clinical Diagnostics Market by Test, 2021-2031, $ mn
Table 34. Spain Clinical Diagnostics Market by Product, 2021-2031, $ mn
Table 35. Spain Clinical Diagnostics Market by Indication, 2021-2031, $ mn
Table 36. Italy Clinical Diagnostics Market by Test, 2021-2031, $ mn
Table 37. Italy Clinical Diagnostics Market by Product, 2021-2031, $ mn
Table 38. Italy Clinical Diagnostics Market by Indication, 2021-2031, $ mn
Table 39. Russia Clinical Diagnostics Market by Test, 2021-2031, $ mn
Table 40. Russia Clinical Diagnostics Market by Product, 2021-2031, $ mn
Table 41. Russia Clinical Diagnostics Market by Indication, 2021-2031, $ mn
Table 42. Clinical Diagnostics Market in Rest of Europe by Country, 2021-2031, $ mn
Table 43. APAC Clinical Diagnostics Market by Country, 2021-2031, $ mn
Table 44. Japan Clinical Diagnostics Market by Test, 2021-2031, $ mn
Table 45. Japan Clinical Diagnostics Market by Product, 2021-2031, $ mn
Table 46. Japan Clinical Diagnostics Market by Indication, 2021-2031, $ mn
Table 47. China Clinical Diagnostics Market by Test, 2021-2031, $ mn
Table 48. China Clinical Diagnostics Market by Product, 2021-2031, $ mn
Table 49. China Clinical Diagnostics Market by Indication, 2021-2031, $ mn
Table 50. Australia Clinical Diagnostics Market by Test, 2021-2031, $ mn
Table 51. Australia Clinical Diagnostics Market by Product, 2021-2031, $ mn
Table 52. Australia Clinical Diagnostics Market by Indication, 2021-2031, $ mn
Table 53. India Clinical Diagnostics Market by Test, 2021-2031, $ mn
Table 54. India Clinical Diagnostics Market by Product, 2021-2031, $ mn
Table 55. India Clinical Diagnostics Market by Indication, 2021-2031, $ mn
Table 56. South Korea Clinical Diagnostics Market by Test, 2021-2031, $ mn
Table 57. South Korea Clinical Diagnostics Market by Product, 2021-2031, $ mn
Table 58. South Korea Clinical Diagnostics Market by Indication, 2021-2031, $ mn
Table 59. Clinical Diagnostics Market in Rest of APAC by Country/Region, 2021-2031, $ mn
Table 60. South America Clinical Diagnostics Market by Country, 2021-2031, $ mn
Table 61. Argentina Clinical Diagnostics Market by Test, 2021-2031, $ mn
Table 62. Argentina Clinical Diagnostics Market by Product, 2021-2031, $ mn
Table 63. Argentina Clinical Diagnostics Market by Indication, 2021-2031, $ mn
Table 64. Brazil Clinical Diagnostics Market by Test, 2021-2031, $ mn
Table 65. Brazil Clinical Diagnostics Market by Product, 2021-2031, $ mn
Table 66. Brazil Clinical Diagnostics Market by Indication, 2021-2031, $ mn
Table 67. Chile Clinical Diagnostics Market by Test, 2021-2031, $ mn
Table 68. Chile Clinical Diagnostics Market by Product, 2021-2031, $ mn
Table 69. Chile Clinical Diagnostics Market by Indication, 2021-2031, $ mn
Table 70. MEA Clinical Diagnostics Market by Country, 2021-2031, $ mn
Table 71. UAE Clinical Diagnostics Market by Test, 2021-2031, $ mn
Table 72. UAE Clinical Diagnostics Market by Product, 2021-2031, $ mn
Table 73. UAE Clinical Diagnostics Market by Indication, 2021-2031, $ mn
Table 74. Saudi Arabia Clinical Diagnostics Market by Test, 2021-2031, $ mn
Table 75. Saudi Arabia Clinical Diagnostics Market by Product, 2021-2031, $ mn
Table 76. Saudi Arabia Clinical Diagnostics Market by Indication, 2021-2031, $ mn
Table 77. South Africa Clinical Diagnostics Market by Test, 2021-2031, $ mn
Table 78. South Africa Clinical Diagnostics Market by Product, 2021-2031, $ mn
Table 79. South Africa Clinical Diagnostics Market by Indication, 2021-2031, $ mn
Table 80. Abbott Laboratories: Company Snapshot
Table 81. Abbott Laboratories: Business Segmentation
Table 82. Abbott Laboratories: Product Portfolio

List Of Figures

LIST OF FIGURES:

Figure 1. Research Method Flow Chart
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation
Figure 3. Global Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2021-2031
Figure 4. Global Clinical Diagnostics Market, 2021-2031, $ mn
Figure 5. Impact of COVID-19 on Business
Figure 6. Primary Drivers and Impact Factors of Global Clinical Diagnostics Market
Figure 7. Leading Causes of Death in the World, 2019-2020, million
Figure 8. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million
Figure 9. World Population 65 and Over, % of Total Population, 1950-2060
Figure 10. Primary Restraints and Impact Factors of Global Clinical Diagnostics Market
Figure 11. Investment Opportunity Analysis
Figure 12. Porter’s Fiver Forces Analysis of Global Clinical Diagnostics Market
Figure 13. Breakdown of Global Clinical Diagnostics Market by Test, 2021-2031, % of Revenue
Figure 14. Global Addressable Market Cap in 2022-2031 by Test, Value ($ mn) and Share (%)
Figure 15. Global Clinical Diagnostics Market by Test: Lipid Panel, 2021-2031, $ mn
Figure 16. Global Clinical Diagnostics Market by Test: Infectious Disease Testing, 2021-2031, $ mn
Figure 17. Global Clinical Diagnostics Market by Test: Liver Panel, 2021-2031, $ mn
Figure 18. Global Clinical Diagnostics Market by Test: Complete Blood Count (CBC), 2021-2031, $ mn
Figure 19. Global Clinical Diagnostics Market by Test: Electrolyte Testing, 2021-2031, $ mn
Figure 20. Global Clinical Diagnostics Market by Test: Renal Panel, 2021-2031, $ mn
Figure 21. Global Clinical Diagnostics Market by Test: Other Tests, 2021-2031, $ mn
Figure 22. Breakdown of Global Clinical Diagnostics Market by Product, 2021-2031, % of Sales Revenue
Figure 23. Global Addressable Market Cap in 2022-2031 by Product, Value ($ mn) and Share (%)
Figure 24. Global Clinical Diagnostics Market by Product: Instruments, 2021-2031, $ mn
Figure 25. Global Clinical Diagnostics Market by Product: Assay Kits & Reagents, 2021-2031, $ mn
Figure 26. Global Clinical Diagnostics Market by Product: Software & Services, 2021-2031, $ mn
Figure 27. Breakdown of Global Clinical Diagnostics Market by Indication, 2021-2031, % of Sales Revenue
Figure 28. Global Addressable Market Cap in 2022-2031 by Indication, Value ($ mn) and Share (%)
Figure 29. Global Clinical Diagnostics Market by Indication: Cardiovascular, 2021-2031, $ mn
Figure 30. Global Clinical Diagnostics Market by Indication: Cancer, 2021-2031, $ mn
Figure 31. Global Clinical Diagnostics Market by Indication: Infectious Disease, 2021-2031, $ mn
Figure 32. Global Clinical Diagnostics Market by Indication: Stroke, 2021-2031, $ mn
Figure 33. Global Clinical Diagnostics Market by Indication: Chronic Lower Respiratory Diseases, 2021-2031, $ mn
Figure 34. Global Clinical Diagnostics Market by Indication: Diabetes, 2021-2031, $ mn
Figure 35. Global Clinical Diagnostics Market by Indication: Other Indications, 2021-2031, $ mn
Figure 36. Breakdown of Global Clinical Diagnostics Market by Patient Gender, 2021-2031, % of Revenue
Figure 37. Global Addressable Market Cap in 2022-2031 by Patient Gender, Value ($ mn) and Share (%)
Figure 38. Global Clinical Diagnostics Market by Patient Gender: Male Patients, 2021-2031, $ mn
Figure 39. Global Clinical Diagnostics Market by Patient Gender: Female Patients, 2021-2031, $ mn
Figure 40. Breakdown of Global Clinical Diagnostics Market by Age Group, 2021-2031, % of Revenue
Figure 41. Global Addressable Market Cap in 2022-2031 by Age Group, Value ($ mn) and Share (%)
Figure 42. Global Clinical Diagnostics Market by Age Group: Age 44 and below, 2021-2031, $ mn
Figure 43. Global Clinical Diagnostics Market by Age Group: Age 45-64, 2021-2031, $ mn
Figure 44. Global Clinical Diagnostics Market by Age Group: Age 65 and over, 2021-2031, $ mn
Figure 45. Breakdown of Global Clinical Diagnostics Market by End User, 2021-2031, % of Revenue
Figure 46. Global Addressable Market Cap in 2022-2031 by End User, Value ($ mn) and Share (%)
Figure 47. Global Clinical Diagnostics Market by End User: Hospital & Clinics Laboratory, 2021-2031, $ mn
Figure 48. Global Clinical Diagnostics Market by End User: Diagnostic Laboratory, 2021-2031, $ mn
Figure 49. Global Clinical Diagnostics Market by End User: Point-of-Care Testing, 2021-2031, $ mn
Figure 50. Global Clinical Diagnostics Market by End User: Other End Users, 2021-2031, $ mn
Figure 51. Global Market Snapshot by Region
Figure 52. Geographic Spread of Worldwide Clinical Diagnostics Market, 2021-2031, % of Sales Revenue
Figure 53. Global Addressable Market Cap in 2022-2031 by Region, Value ($ mn) and Share (%)
Figure 54. North American Clinical Diagnostics Market, 2021-2031, $ mn
Figure 55. Breakdown of North America Clinical Diagnostics Market by Country, 2021 and 2031, % of Revenue
Figure 56. Contribution to North America 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%)
Figure 57. U.S. Clinical Diagnostics Market, 2021-2031, $ mn
Figure 58. Percent Distribution of the 10 Leading Causes of Death by Gender in United States, 2019, %
Figure 59. Percent Distribution of the 10 Leading Causes of Death by Age Group in United States, 2019, %
Figure 60. Canada Clinical Diagnostics Market, 2021-2031, $ mn
Figure 61. Clinical Diagnostics Market in Mexico, 2021-2031, $ mn
Figure 62. European Clinical Diagnostics Market, 2021-2031, $ mn
Figure 63. Breakdown of European Clinical Diagnostics Market by Country, 2021 and 2031, % of Revenue
Figure 64. Contribution to Europe 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%)
Figure 65. Clinical Diagnostics Market in Germany, 2021-2031, $ mn
Figure 66. Clinical Diagnostics Market in U.K., 2021-2031, $ mn
Figure 67. Clinical Diagnostics Market in France, 2021-2031, $ mn
Figure 68. Clinical Diagnostics Market in Spain, 2021-2031, $ mn
Figure 69. Clinical Diagnostics Market in Italy, 2021-2031, $ mn
Figure 70. Clinical Diagnostics Market in Russia, 2021-2031, $ mn
Figure 71. Clinical Diagnostics Market in Rest of Europe, 2021-2031, $ mn
Figure 72. Asia-Pacific Clinical Diagnostics Market, 2021-2031, $ mn
Figure 73. Breakdown of APAC Clinical Diagnostics Market by Country, 2021 and 2031, % of Revenue
Figure 74. Contribution to APAC 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%)
Figure 75. Clinical Diagnostics Market in Japan, 2021-2031, $ mn
Figure 76. Clinical Diagnostics Market in China, 2021-2031, $ mn
Figure 77. Clinical Diagnostics Market in Australia, 2021-2031, $ mn
Figure 78. Clinical Diagnostics Market in India, 2021-2031, $ mn
Figure 79. Clinical Diagnostics Market in South Korea, 2021-2031, $ mn
Figure 80. Clinical Diagnostics Market in Rest of APAC, 2021-2031, $ mn
Figure 81. South America Clinical Diagnostics Market, 2021-2031, $ mn
Figure 82. Breakdown of South America Clinical Diagnostics Market by Country, 2021 and 2031, % of Revenue
Figure 83. Contribution to South America 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%)
Figure 84. Clinical Diagnostics Market in Argentina, 2021-2031, $ mn
Figure 85. Clinical Diagnostics Market in Brazil, 2021-2031, $ mn
Figure 86. Clinical Diagnostics Market in Chile, 2021-2031, $ mn
Figure 87. Clinical Diagnostics Market in Rest of South America, 2021-2031, $ mn
Figure 88. Clinical Diagnostics Market in Middle East and Africa (MEA), 2021-2031, $ mn
Figure 89. Breakdown of MEA Clinical Diagnostics Market by Country, 2021 and 2031, % of Revenue
Figure 90. Contribution to MEA 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%)
Figure 91. Clinical Diagnostics Market in UAE, 2021-2031, $ mn
Figure 92. Clinical Diagnostics Market in Saudi Arabia, 2021-2031, $ mn
Figure 93. Clinical Diagnostics Market in South Africa, 2021-2031, $ mn
Figure 94. Growth Stage of Global Clinical Diagnostics Industry over the Forecast Period